News
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
TODAY on MSN22h
Study Finds Weight-Loss Meds May Lower Dementia, Stroke RiskA new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
A WOMAN has revealed how shedding a whopping 8st completely transformed her life but also landed her in a major surgery. The weight loss warrior, Em, has been documenting her transformation on her ...
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
Presented by AstraZeneca{beacon} Health Care Health Care The Big Story CMS targets hospitals with site-neutral drug ruleThe ...
2m
TAG24 on MSNWeight loss jabs linked to lower dementia and stroke riskWeight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
YoCrunch yogurt products are being pulled from store shelves nationwide due to a safety concern -- plastic in the dome -- its ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results